Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.16p
   
  • Change Today:
      0.005p
  • 52 Week High: 0.75
  • 52 Week Low: 0.14
  • Currency: UK Pounds
  • Shares Issued: 1,320.30m
  • Volume: 0
  • Market Cap: £2.05m
  • RiskGrade: 435

Deal with Barclays    Trade now with Barclays Stockbrokers

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
05-Nov-15 Northland Capital Partners Corporate 26.00p - - Reiteration
16-Sep-15 Northland Capital Partners Corporate 26.50p - - Reiteration
14-Oct-14 Daniel Stewart Buy - 1.05p 1.05p Reiteration
04-Aug-14 Daniel Stewart Buy - 1.05p 1.05p Reiteration
10-Jun-14 Daniel Stewart Buy - 1.05p 1.05p Reiteration
16-May-14 Daniel Stewart Buy - 1.05p 1.05p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Valirx Market Data

Currency UK Pounds
Share Price 0.16p
Change Today 0.005p
% Change -3.13 %
52 Week High 0.75
52 Week Low 0.14
Volume 0
Shares Issued 1,320.30m
Market Cap £2.05m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
41.52% above the market average41.52% above the market average41.52% above the market average41.52% above the market average41.52% above the market average
46.34% above the sector average46.34% above the sector average46.34% above the sector average46.34% above the sector average46.34% above the sector average
Price Trend
87.83% below the market average87.83% below the market average87.83% below the market average87.83% below the market average87.83% below the market average
81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average
Income Not Available
Growth
26.62% above the market average26.62% above the market average26.62% above the market average26.62% above the market average26.62% above the market average
31.03% above the sector average31.03% above the sector average31.03% above the sector average31.03% above the sector average31.03% above the sector average

Valirx Dividends

No dividends found

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

Valirx Key Personnel

CFO Gerald Desler

Top of Page